E-选择素 (CD62E) 是一种在内皮细胞上表达的粘附分子。E-选择素分子由五个独特的成分组成,包括与配体相互作用的氨基末端凝集素结构域、表皮生长因子 (EGF) 样结构域、补体调节样结构域、跨膜结构域和 C 末端胞质尾。E-选择素表达由炎症刺激和氧化应激诱导,其表达水平与内皮细胞损伤相关。抑制 E-选择素可能会减少血栓形成、血管渗漏和癌症转移[1]。
E-selectin (CD62E) is an adhesion molecule expressed on endothelial cells. The E-selectin molecule consists of five unique components, including an amino-terminal lectin domain that interacts with ligands, an epidermal growth factor (EGF)-like domain, a complement regulatory-like domain, a transmembrane domain, and a C-terminal cytoplasmic tail. E-selectin expression is induced by inflammatory stimuli and oxidative stress, and its expression levels correlate with endothelial cell damage. Inhibition of E-selectin may reduce thrombosis, vascular leakage, and cancer metastasis[1].
Rivipansel 是一种小分子糖模拟物泛选择素拮抗剂,对 E-selectin 和 P-selectin 具有抑制活性,可与 E-selectin 的凝集素结构域紧密结合并选择性阻断 E-selectin 对 CD62L 的识别,且不影响 PSGL-1 与 E-selectin 的结合,从而在功能上抑制造血细胞与内皮细胞的黏附,可用于镰状细胞病相关研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号